LEADERSHIP TO MOVE THE FIELD FORWARD

​Our management team and current advisors have experience and expertise in advancing product candidates through clinical development and in implementing comprehensive global commercialization strategies in combination with established pharmaceutical partners and regional distributors. We bring experience in global women’s healthcare, fundraising, clinical and regulatory strategy and implementation, partnering and commercial product launches. Our expertise covers devices, therapeutics and diagnostics.

Management team


Sabrina Martucci Johnson

President and Chief Executive Officer

Ms. Johnson founded Daré Science Operations, Inc. in 2015 and has served as President, CEO and a member of the Board of Directors since the company’s inception. The company was acquired through a reverse merger by Cerulean Pharma Inc. on July 19, 2017, and Ms. Johnson assumed the roles of President, CEO and a member of the Board of Directors of the renamed company, Daré Bioscience, Inc.  Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare. Prior to founding Daré, Ms. Johnson was President of WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare with commercial product distribution in over 100 countries, from October of 2014 to May of 2015. Before serving as President of WomanCare Global Trading, Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the for-profit Trading division as well as the United Kingdom-based non-profit division, from November of 2012 to July of 2013, when she joined full time as WomanCare’s Chief Financial Officer and Chief Operating Officer until becoming President of the Trading division. In addition, Ms. Johnson served as Chief Operating Officer and Chief Financial Officer of Cypress Bioscience, Inc. until its sale in 2010. Ms. Johnson also held marketing and sales positions with Advanced Tissue Sciences and Clonetics Corporation. She began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on their recombinant factor VIII program.  

Ms. Johnson currently serves on the YWCA of San Diego County Board of Directors as Past President, PPPSW Board of Directors, Athena San Diego Board of Directors as Vice Chair, Tulane University School of Science & Engineering Board of Advisors, University of California San Diego (UCSD) Librarian’s Advisory Board as Chair and Project Concern International Audit Committee. Ms. Johnson is also Immediate Past Co-President of Women Give San Diego, which funds non-profit organizations serving women and girls in San Diego.​

Sabrina has an MIM from the American Graduate School of International Management (Thunderbird) with honors, a MSc. in Biochemical Engineering from the University of London, University College London, and a BSc. in Biomedical Engineering from Tulane University, where she graduated magna cum laude.


Lisa Walters-Hoffert

Chief Financial Officer

Ms. Walters-Hoffert co-founded Daré Bioscience Operations, Inc. in 2015 and has served as Chief Business Officer since the company’s inception. In March of 2017 she assumed the role of Chief Financial Officer, and following the company’s acquisition through a reverse merger by Cerulean Pharma Inc. on July 19, 2017, she has continued in this role with the renamed company, Daré Bioscience, Inc. During the 25 years prior to Daré, Lisa was an investment banker focused primarily on raising equity capital for, and providing advisory services to, small-cap public companies. She worked for Roth Capital Partners, an investment banking firm dedicated to small cap companies, from 2003 until January of 2015, where she most recently served as Managing Director in the Investment Banking Division, overseeing the firm’s San Diego office and its activities with respect to medical device, diagnostic and specialty pharma companies. At Roth Capital Partners, Ms. Walters-Hoffert trained and managed deal teams and was responsible for the oversight of all aspects of transactions, including due diligence, internal communications with sales forces and external communications with institutional investors, among others. Lisa has held various positions in the corporate finance and investment banking divisions of Citicorp Securities in San José, Costa Rica and Oppenheimer & Co, Inc. in New York City, New York. 

Ms. Walters-Hoffert has served as a member of the Board of Directors of the San Diego Venture Group, as Past Chair of the UCSD Librarian’s Advisory Board and as Immediate Past Chair of the Board of Planned Parenthood of the Pacific Southwest. Ms. Walters-Hoffert graduated from Duke University with a BS in Management Sciences, magna cum laude.


Mark Walters

Vice President, Operations

Mr. Walters co-founded Daré Bioscience Operations, Inc. in 2015 and has served as Vice President of Operations and Projects since the company’s inception. Following the company’s acquisition through a reverse merger by Cerulean Pharma Inc. on July 19, 2017, he has continued in this role with the renamed company, Daré Bioscience, Inc. Prior to Daré, he was President of Walters Consulting Partners where he advised the pharmaceutical and medical device industries on business development, development and regulatory approaches, and corporate and commercialization strategies.   Mark served as Senior Vice President, Technical Operations and Vice President, Business and Commercial Development for Pacira Pharmaceuticals, and SkyePharma prior to its acquisition by Pacira.  He spent twelve years at Alliance Pharmaceutical Corp. in various roles directing product development, project management, marketing and sales.  Mr. Walters is an inventor on six issued patents in the fields of imaging and ventilator support.  He received his degree in biology from Hamilton College.